Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
10.1021/acs.jafc.8b00988 J
Supplementary Table 8 and Extended Data Fig
Gabapentin, licensed for epilepsy and neuropathic pain, works through neurological pathways, whilst Wegovy (semaglutide 2.4mg), a GLP-1 receptor agonist, influences appetite regulation and weight management
Coding Best Practices for GLP-1 Claims Always verify payer coverage policies Confirm FDA-approved indication Use the most specific ICD-10 code Include BMI codes when required Ensure documentation supports medical necessity Confirm whether the drug is pharmacy or medical benefit Avoid unclassified J-codes unless required Track prior authorization approvals Document patient counseling and monitoring Watch for Medicare weight-loss exclusions Denial Prevention Checklist Before submitting GLP-1-related claims, confirm: Correct diagnosis code selection BMI documented and coded PA approval on file Proper benefit type (pharmacy vs medical) E/M level supported by documentation Drug coverage confirmed by payer GLP-1 medications are transforming diabetes and obesity care, but they bring complex billing and compliance challenges
minutes)
